Human pancreatic cancer stem cells: Implications for how we treat pancreatic cancer

Translational Oncology

Volumn 1, Issue 1, 2008, Pages 14-18

  Lee, Cheong J ^a   Li, Chenwei ^a   Simeone, Diane M ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70350068976     PISSN: None     EISSN: 19365233     Source Type: Journal    
DOI: 10.1593/tlo.08013     Document Type: Article

References (44)

1. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, and Clarke MF (2003). Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100 (7), 3983-3988.
2. Collins AT, Berry PA, Hyde C, Stower MJ, and Maitland NJ (2005). Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 65 (23), 10946-10951.
3. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, Henkelman RM, Cusimano MD, and Dirks PB (2004). Identification of human brain tumour initiating cells. Nature 432 (7015), 396-401.
4. O'Brien CA, Pollett A, Gallinger S, and Dick JE (2007). A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445 (7123), 106-110.
5. Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C, and De Maria R (2007). Identification and expansion of human colon-cancer- initiating cells. Nature 445 (7123), 111-115.
6. Bonnet D and Dick JE (1997). Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 3 (7), 730-737.
7. Ponta H, Sherman L, and Herrlich PA (2003). CD44: from adhesion molecules to signalling regulators. Nat Rev Mol Cell Biol 4 (1), 33-45.
8. Weichert W, Denkert C, Burkhardt M, Gansukh T, Bellach J, Altevogt P, Dietel M, and Kristiansen G (2005). Cytoplasmic CD24 expression in colorectal cancer independently correlates with shortened patient survival. Clin Cancer Res 11 (18), 6574-6581.
9. Jin L, Hope KJ, Zhai Q, Smadja-Joffe F, and Dick JE (2006). Targeting of CD44 eradicates human acute myeloid leukemic stem cells. Nat Med 12 (10), 1167-1174.
10. Liu S, Dontu G, Mantle ID, Pastel S, Ahn NS, Jackson KW, Suri P, and Wicha MS (2006). Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Res 66 (12), 6063-6071.
11. Li C, Heidt DG, Dalcrba P, Burant CF, Zhang L, Adsay V, Wicha M, Clarke MF, and Simeone DM (2007). Identification of pancreatic cancer stem cells. Cancer Res 67 (3), 1030-1037.
12. Hermann PC, Huber SL, Herrler T, Aicher A, Ellwart JW, Guba M, Bruns CJ, and Heeschen C (2007). Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 1, 313-323.
13. Huang EH, Heidt DG, Li CW, and Simeone DM (2007). Cancer stem cells: a new paradigm for understanding tumor progression and therapeutic resistance. Surgery 141 (4), 415-419.
14. Lessard J and Sauvageau G (2003). Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature 423 (6937), 255-260.
15. Dontu G, Jackson KW, McNicholas E, Kawamura MJ, Abdallah WM, and Wicha MS (2004). Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells. Breast Cancer Res 6 (6), R605-R615.
16. Yilmaz OH, Valdez R, Theisen BK, Guo W, Ferguson DO, Wu H, and Morrison SJ (2006). PTEN dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells. Nature 441 (7092), 475-482.
17. Clement V, Sanchez P, de Tribolet N, Radovanovic I, and Ruiz i Altaba A (2007). HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity. Curr Biol 17 (2), 165-172.
18. Thayer SP, di Magliano MP, Heiser PW, Neilsen CM, Roberts DJ, Lauwers GY, Qi YP, Gysin S, Fernandez-del Castillo C, Yajnik V, et al. (2003). Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature 425 (6960), 851-856.
19. Berman DM, Karhadkar SS, Maitra A, Montes De Oca R, Gerstenblith MR, Briggs K, Parker AR, Shimada Y, Eshleman JR, Watkins DN, et al. (2003). Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours. Nature 425 (6960), 846-851.
20. Kim JH, Yoon SY, Jeong SH, Joo JH, Moon SK, Choe IS, Choe YK, and Kim JW (2004). Overexpression of Bmi-1 oncoprotein correlates with axillary lymph node metastases in invasive ductal breast cancer. Breast 13 (5), 383-388.
21. Cui H, Hu B, Li T, Ma J, Alam G, Gunning WT, and Ding HF (2007). Bmi-1 is essential for the tumorigenicity of neuroblastoma cells. Am J Pathol 170 (4), 1370-1378.
22. ARF proteins. Cancer Lett 203 (2), 217-224.
23. Kang MK, Kim RH, Kim SJ, Yip FK, Shin KH, Dimri GP, Christensen R, Han T, and Park NH (2007). Elevated Bmi-1 expression is associated with dysplastic cell transformation during oral carcinogenesis and is required for cancer cell replication and survival. Br J Cancer 96 (1), 126-133.
24. Molofsky AV, He S, Bydon M, Morrison SJ, and Pardal R (2005). Bmi-1 promotes neural stem cell self-renewal and neural development but not mouse growth and survival by repressing the p16Ink4a and p19Arf senescence pathways. Genes Dev 19 (12), 1432-1437.
25. Park IK, Qian D, Kiel M, Becker MW, Pihalja M, Weissman IL, Morrison SJ, and Clarke MF (2003). Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature 423 (6937), 302-305.
26. van der Lugt NM, Domen J, Linders K, van Roon M, Robanus-Maandag E, te Riele H, van der Valk M, Deschamps J, Sofroniew M, van Lohuizen M, et al. (1994). Posterior transformation, neurological abnormalities, and severe hematopoietic defects in mice with a targeted deletion of the bmi-1 proto-oncogene. Genes Dev 8 (7), 757-769.
27. Cui H, Ma J, Ding J, Li T, Alam G, and Ding HF (2006). Bmi-1 regulates the differentiation and clonogenic self-renewal of I-type neuroblastoma cells in a concentration-dependent manner. J Biol Chem 281 (45), 34696-34704.
28. Luker KE and Luker GD (2006). Functions of CXCL12 and CXCR4 in breast cancer. Cancer Lett 238 (1), 30-41.
29. Su YC, Wu MT, Huang CJ, Hou MF, Yang SF, and Chai CY (2006). Expression of CXCR4 is associated with axillary lymph node status in patients with early breast cancer. Breast 15 (4), 533-539.
30. Wehler T, Wolfert F, Schimanski CC, Gockel I, Herr W, Biesterfeld S, Seifert JK, Adwan H, Berger MR, Junginger T, et al. (2006). Strong expression of chemokine receptor CXCR4 by pancreatic cancer correlates with advanced disease. Oncol Rep 16 (6), 1159-1164.
31. & progenitor cells have decreased sensitivity to chemotherapy and Fas-induced apoptosis, reduced immunogenicity, and impaired dendritic cell transformation capacities. Cancer Res 60, 4403-4411.
32. Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, Dewhirst MW, Bigner DD, and Rich JN (2006). Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444 (7120), 756-760.
33. Chen MS, Woodward WA, Behbod F, Peddibhotla S, Alfaro MP, Buchholz TA, and Rosen JM (2007). Wnt/beta-catenin mediates radiation resistance of Sca1+ progenitors in an immortalized mammary gland cell line. J Cell Sci 120 (Pt 3), 468-477.
34. Woodward WA, Chen MS, Behbod F, Alfaro MP, Buchholz TA, and Rosen JM (2007). WNT/beta-catenin mediates radiation resistance of mouse mammary progenitor cells. Proc Natl Acad Sci USA 104 (2), 618-623.
35. Ayyanan A, Civenni G, Ciarloni L, Morel C, Mueller N, Lefort K, Mandinova A, Raffoul W, Fiche M, Dotto GP, et al. (2006). Increased Wnt signaling triggers oncogenic conversion of human breast epithelial cells by a Notchdependent mechanism. Proc Natl Acad Sci USA 103 (10), 3799-3804.
36. Asanuma K, Moriai R, Yajima T, Yagihashi A, Yamada M, Kobayashi D, and Watanabe N (2000). Survivin as a radioresistance factor in pancreatic cancer. Jpn J Cancer Res 91 (11), 1204-1209.
37. + breast cancer-initiating cells to radiation. J Natl Cancer Inst 98 (24), 1777-1785.
38. Fan X, Matsui W, Khaki L, Stearns D, Chun J, Li YM, and Eberhart CG (2006). Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain tumors. Cancer Res 66 (15), 7445-7452.
39. Murga M, Jaco I, Fan Y, Soria R, Martinez-Pastor B, Cuadrado M, Yang SM, Blasco MA, Skoultchi AI, and Fernandez-Capetillo O (2007). Global chromatin compaction limits the strength of the DNA damage response. J Cell Biol 178 (7), 1101-1108.
40. Hwang RF, Moore T, Arumugam T, Ramachandran V, Amos KD, Rivera A, Ji B, Evans DB, and Logsdon CD (2008). Cancer-associated fibroblasts promote pancreatic tumor progression. Cancer Res 68 (3), 918-926.
41. Keith B and Simon MC (2007). Hypoxia-inducible factors, stem cells, and cancer. Cell 129 (3), 465-472.
42. Buchler P, Reber HA, Buchler M, Shrinkante S, Buchler MW, Friess H, Semenza GL, and Hines OJ (2003). Hypoxia-inducible factor 1 regulates vascular endothelial growth factor expression in human pancreatic cancer. Pancreas 26 (1), 56-64.
43. Moeller BJ, Richardson RA, and Dewhirst MW (2007). Hypoxia and radiotherapy: opportunities for improved outcomes in cancer treatment. Cancer Metastasis Rev 26 (2), 241-248.
44. Sun HC, Qiu ZJ, Liu J, Sun J, Jiang T, Huang KJ, Yao M, and Huang C (2007). Expression of hypoxia-inducible factor-1 alpha and associated proteins in pancreatic ductal adenocarcinoma and their impact on prognosis. Int J Oncol 6, 1359-1367.